Sunscreens prescribed to patients with skin of color and/or with melasma: A survey of 221 dermatologists and dermatology residents in Spain

Abstract

AbstractBackgroundDark‐skinned individuals (DSI) present high rates of melasma and post‐inflammatory hyperpigmentation. The use of sunscreens with mineral filters is essential for prevention and treatment. Our objective was to determine the preferences of dermatologists and dermatology residents in the prescription of sunscreens for DSI.MethodsAn anonymous survey of attendees at an online photoprotection event held on March 31, 2022, in Spain.ResultsThe survey was answered by 66.6% (221/332) of the attendees: 159 dermatologists (71.9%) and 62 dermatology residents (28.1%). Respondents reported recommending the use of sunscreen to a median of 80% of DSI [interquartile range (IQR), 50–90]. Physicians reported prescribing tinted sunscreens to a median percentage of 60% (IQR, 25–90) of DSI with acne; and to a median percentage of 90% (IQR, 58–99) of DSI with melasma. The most prescribed photoprotectors to DSI with melasma were organic broad‐spectrum sunscreens with antioxidants: 102/220 (46.4%) and mineral broad‐spectrum sunscreens (with iron oxides): 45/220 (20.4%). In DSI with melasma or other pigmentary disorders, the most preferred features of sunscreens were as follows: sun protection factor ≥ 30: 217/221 (98.2%), UVA protection: 214/221 (96.8%), color for camouflage: 150/220 (68.2%) and mineral filters such as titanium dioxide and zinc oxide: 151/220 (68.6%) or iron oxides: 131/220 (59.5%).LimitationsOnline survey, potential inclusion bias.ConclusionsRespondents reported to prescribe sunscreens to the majority of DSI, and tinted sunscreens for the majority of DSI with pigmentary disorders. However, the most frequently recommended sunscreens for DSI were organic broad‐spectrum sunscreens with antioxidants.